Literature DB >> 21666260

Intensive insulin therapy in hospitalised patients increases the risk of hypoglycaemia and has no effect on mortality, infection risk or length of stay.

Ebenezer Nyenwe1.   

Abstract

Entities:  

Year:  2011        PMID: 21666260     DOI: 10.1136/ebm1413

Source DB:  PubMed          Journal:  Evid Based Med        ISSN: 1356-5524


× No keyword cloud information.
  2 in total

1.  Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes.

Authors:  Fu-Ping Lyu; Bing-Kun Huang; Wei-Juan Su; Fang-Fang Yan; Jin-Yang Zeng; Zheng Chen; Yu-Xian Zhang; Shun-Hua Wang; Yin-Xiang Huang; Mu-Lin Zhang; Xiu-Lin Shi; Ming-Zhu Lin; Xue-Jun Li
Journal:  Diabetes Ther       Date:  2020-02-04       Impact factor: 2.945

2.  Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Authors:  Heng Wan; Defu Zhao; Jie Shen; Lu Lu; Tong Zhang; Zhi Chen
Journal:  J Diabetes Res       Date:  2015-12-21       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.